56
Views
0
CrossRef citations to date
0
Altmetric
Special Section: Selected Articles from the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop 2020 - Lead and Impact: Turning Innovation into Practice

Backward Sequential Significance Testing in Survival Trials

Pages 505-510 | Received 20 Nov 2020, Accepted 25 Jul 2022, Published online: 03 Oct 2022

References

  • DeMets, D. L., and Lan, K. K. (1994), “Interim Analysis: The Alpha Spending Function Approach,” Statistics in Medicine, 13, 1341–1352. DOI: 10.1002/sim.4780131308.
  • Fleming, T. R., and Lin, D. Y. (2000), “Survival Analysis in Clinical Trials: Past Developments and Future Directions,” Biometrics, 56, 971–983. DOI: 10.1111/j.0006-341x.2000.0971.x.
  • Gu, M. G., and Lai, T. L. (1991), “Weak Convergence of Time-Sequential Censored Rank Statistics with Applications to Sequential Testing in Clinical Trials,” The Annals of Statistics, 19, 1403–1433. DOI: 10.1214/aos/1176348254.
  • Harrington, D. P., Fleming, T. R., and Green, S. J. (1982), “Procedures for Serial Testing in Censored Survival Data,” in Survival Analysis, eds. J. Crowley and R. A. Johnson, pp. 269–286, Hayward, CA: Institute of Mathematical Statistics.
  • Kim, K., and DeMets, D. L. (1987), “Design and Analysis of Group Sequential Tests based on Type I error Spending Function,” Biometrika, 74, 149–154. DOI: 10.1093/biomet/74.1.149.
  • Lan, K. K. G., and DeMets, D. L. (1983), “Discrete Sequential Boundaries for Clinical Trials,” Biometrika, 70, 659–663. DOI: 10.2307/2336502.
  • Lan, K. K. G., and DeMets, D. L. (1989), “Group Sequential Procedures: Calendar versus Information Time,” Statistics in Medicine, 8, 1191–1198. DOI: 10.1002/sim.4780081003.
  • Mantel, N. (1966), “Evaluation of Survival Data and Two New Rank Order Statistics Arising in its Consideration,” Cancer Chemotherapy Report, 50, 163–170.
  • O’Brien, P. C., and Fleming, T. R. (1979), “A Multi-stage Procedure for Clinical Trials,” Biometrics, 35, 549–556. DOI: 10.2307/2530245.
  • Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., Pfeiffer, E., Sano, M., van Dyck, C. H., and Thal, L. J., for the Alzheimer’s Disease Cooperative Study Group (2005), “Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment,” The New England Journal of Medicine, 352, 2379–2388. DOI: 10.1056/NEJMoa050151.
  • Peto, R., and Peto, J. (1972), “Asymptotically Efficient Rank Invariant Test Procedures” (with discussion), Journal of the Royal Statistical Society, Series A, 135, 185–206. DOI: 10.2307/2344317.
  • Pocock, S. J. (1977), “Group Sequential Methods in the Design and Analysis of Clinical Trials,” Biometrika, 64, 191–199. DOI: 10.1093/biomet/64.2.191.
  • Slud, E. V. (1984), “Sequential Linear Rank Tests for Two-Sample Censored Survival Data,” The Annals of Statistics, 12, 551–571. DOI: 10.1214/aos/1176346505.
  • Slud, E. V., and Wei, L. J. (1982), “Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistics,” Journal of the American Statistical Association, 77, 862–868. DOI: 10.1080/01621459.1982.10477899.
  • Statistical Analysis System (SAS). (2016). Version 9.4 SAS Institute Inc., Cary, NC.
  • Tsiatis, A. A. (1982), “Repeated Significance Testing for a General Class of Statistics Used in Censored Survival Analysis,” Journal of the American Statistical Association, 77, 855–861. DOI: 10.1080/01621459.1982.10477898.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.